Valensa’s Chief Science Officer Presents New Research on Efficacy of a Lipidosterolic Extract of Saw Palmetto
In collaboration with Valensa, leading prostate expert Dr. Stephen Strum has published the most comprehensive, global review of clinical studies to evaluate the consumer benefit of a lipidosterolic extract of Serenoa repens (LSESr), commonly known as saw palmetto. Through an assessment of 40 years of data Strum’s findings validate the effectiveness of an LSESr like Valensa’s USPlus® […]
Read More »